About
Phare Bio is a social venture leveraging generative AI and deep learning to discover and develop novel antibiotics aimed at addressing the global antimicrobial resistance crisis, progressing candidates through preclinical development with a unique funding model.
Explore Phare Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.